132 related articles for article (PubMed ID: 9773795)
1. Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors.
Little J; Phillips L; Russell L; Griffiths A; Russell GI; Davies SJ
J Am Soc Nephrol; 1998 Oct; 9(10):1931-9. PubMed ID: 9773795
[TBL] [Abstract][Full Text] [Related]
2. The uremic dyslipidemia: a cross-sectional and longitudinal study.
Avram MM; Goldwasser P; Burrell DE; Antignani A; Fein PA; Mittman N
Am J Kidney Dis; 1992 Oct; 20(4):324-35. PubMed ID: 1415199
[TBL] [Abstract][Full Text] [Related]
3. Fibrinogen, coagulation factor VII, tissue plasminogen activator, plasminogen activator inhibitor-1, and lipid as cardiovascular risk factors in chronic hemodialysis and continuous ambulatory peritoneal dialysis patients.
Tomura S; Nakamura Y; Doi M; Ando R; Ida T; Chida Y; Ootsuka S; Shinoda T; Yanagi H; Tsuchiya S; Marumo F
Am J Kidney Dis; 1996 Jun; 27(6):848-54. PubMed ID: 8651250
[TBL] [Abstract][Full Text] [Related]
4. Prevalence of hyperlipidemia in a cohort of CAPD patients. Italian Cooperative Peritoneal Dialysis Study Group (ICPDSG).
Cocchi R; Viglino G; Cancarini G; Catizone L; Favazza A; Tommasi A; Salomone M; Segoloni GP; Torpia R; Giangrande A
Miner Electrolyte Metab; 1996; 22(1-3):22-5. PubMed ID: 8676819
[TBL] [Abstract][Full Text] [Related]
5. Serum lipid profiles including non-high density lipoprotein cholesterol levels in Turkish school-children.
Uçar B; Kiliç Z; Dinleyici EC; Colak O; Güneş E
Anadolu Kardiyol Derg; 2007 Dec; 7(4):415-20. PubMed ID: 18065339
[TBL] [Abstract][Full Text] [Related]
6. Lipid parameters including lipoprotein (a) in patients undergoing CAPD and hemodialysis.
Siamopoulos KC; Elisaf MS; Bairaktari HT; Pappas MB; Sferopoulos GD; Nikolakakis NG
Perit Dial Int; 1995; 15(8):342-7. PubMed ID: 8785232
[TBL] [Abstract][Full Text] [Related]
7. The impact of CAPD treatment on lipid metabolism and cardiovascular risk.
Tan D; Fein PA; Antignani A; Mittman N; Avram MM
Adv Perit Dial; 1990; 6():233-7. PubMed ID: 1982815
[TBL] [Abstract][Full Text] [Related]
8. Higher serum triglyceride to high-density lipoprotein cholesterol ratio was associated with increased cardiovascular mortality in female patients on peritoneal dialysis.
Wu H; Xiong L; Xu Q; Wu J; Huang R; Guo Q; Mao H; Yu X; Yang X
Nutr Metab Cardiovasc Dis; 2015 Aug; 25(8):749-55. PubMed ID: 26084271
[TBL] [Abstract][Full Text] [Related]
9. Peritoneal transport characteristics, comorbid diseases and survival in CAPD patients.
Chung SH; Chu WS; Lee HA; Kim YH; Lee IS; Lindholm B; Lee HB
Perit Dial Int; 2000; 20(5):541-7. PubMed ID: 11117245
[TBL] [Abstract][Full Text] [Related]
10. Is atherosclerosis accelerated by CAPD?
Kawaguchi Y; Kubo H; Yamamoto H; Nakayama M; Yokoyama K; Shigematsu T; Sakai O
Perit Dial Int; 1996; 16 Suppl 1():S223-30. PubMed ID: 8728197
[TBL] [Abstract][Full Text] [Related]
11. Six-month prospective cross-over study to determine the effects of 1.1% amino acid dialysate on lipid metabolism in patients on continuous ambulatory peritoneal dialysis.
Misra M; Reaveley DA; Ashworth J; Muller B; Seed M; Brown EA
Perit Dial Int; 1997; 17(3):279-86. PubMed ID: 9237290
[TBL] [Abstract][Full Text] [Related]
12. Serum carnitine levels, lipid profile, and metabolic status of patients on continuous ambulatory peritoneal dialysis.
Pliakogiannis T; Chatzidimitriou C; Evangeliou A; Böhles HJ; Kalaitzidis K
Perit Dial Int; 1993; 13 Suppl 2():S440-3. PubMed ID: 8399635
[TBL] [Abstract][Full Text] [Related]
13. Fall of cholesterol with time on dialysis: impact on atherogenicity.
Lapuz M; Avram MM; Lustig A; Goldwasser P; Antignani A; Fein PA; Mittman N
ASAIO Trans; 1989; 35(3):258-60. PubMed ID: 2597459
[TBL] [Abstract][Full Text] [Related]
14. Residual renal function affects lipid profile in patients undergoing continuous ambulatory peritoneal dialysis.
Kagan A; Elimalech E; Lemer Z; Fink A; Bar-Khayim Y
Perit Dial Int; 1997; 17(3):243-9. PubMed ID: 9237284
[TBL] [Abstract][Full Text] [Related]
15. Circulating soluble vascular cell adhesion molecule 1: relationships with residual renal function, cardiac hypertrophy, and outcome of peritoneal dialysis patients.
Wang AY; Lam CW; Wang M; Woo J; Chan IH; Lui SF; Sanderson JE; Li PK
Am J Kidney Dis; 2005 Apr; 45(4):715-29. PubMed ID: 15806475
[TBL] [Abstract][Full Text] [Related]
16. High glucose concentrations in peritoneal dialysate are associated with all-cause and cardiovascular disease mortality in continuous ambulatory peritoneal dialysis patients.
Wen Y; Guo Q; Yang X; Wu X; Feng S; Tan J; Xu R; Yu X
Perit Dial Int; 2015; 35(1):70-7. PubMed ID: 24293666
[TBL] [Abstract][Full Text] [Related]
17. Higher Serum Total Cholesterol to High-Density Lipoprotein Cholesterol Ratio Is Associated with Increased Mortality among Incident Peritoneal Dialysis Patients.
Noh HW; Jeon Y; Kim JH; Lee GY; Jeon SJ; Kim KY; Lim JH; Jung HY; Choi JY; Park SH; Kim CD; Kim YL; Cho JH
Nutrients; 2021 Dec; 14(1):. PubMed ID: 35011019
[TBL] [Abstract][Full Text] [Related]
18. Hyperlipidemia and long-term outcomes in nondiabetic chronic kidney disease.
Chawla V; Greene T; Beck GJ; Kusek JW; Collins AJ; Sarnak MJ; Menon V
Clin J Am Soc Nephrol; 2010 Sep; 5(9):1582-7. PubMed ID: 20558558
[TBL] [Abstract][Full Text] [Related]
19. Changes in lipid measures and incident coronary heart disease: Tehran Lipid & Glucose Study.
Nejat A; Mirbolouk M; Mohebi R; Hasheminia M; Tohidi M; Saadat N; Azizi F; Hadaegh F
Clin Biochem; 2014 Sep; 47(13-14):1239-44. PubMed ID: 24657509
[TBL] [Abstract][Full Text] [Related]
20. Hyperlipidemia in pediatric patients undergoing peritoneal dialysis.
Querfeld U; Salusky IB; Nelson P; Foley J; Fine RN
Pediatr Nephrol; 1988 Oct; 2(4):447-52. PubMed ID: 3153058
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
